{
"html_url": "https://licitia.com.mx/adjudicacion/aa-12-ndf-012ndf999-i-187-2024",
"canonical": "https://licitia.com.mx/adjudicacion/aa-12-ndf-012ndf999-i-187-2024",
"id": "6cd842c4d19f4c7db3789a5bb7829458",
"procedure_number": "AA-12-NDF-012NDF999-I-187-2024",
"file_number": "E-2024-00032820",
"title": "CONSOLIDADO/INSABI/INRLGII/215/2023-2024 PHARMA TYCSA S.A. DE C.V.",
"description": {
"short": "No existen bienes alternativos o sustitutos, Único Oferente, Derechos exclusivos (patentes, licencias, derechos de autor u otros derechos exclusivos), o por obras de arte.",
"detailed": "PROCEDIMIENTO DE LICITACIÓN PÚBLICA INTERNACIONAL ABIERTA ELECTRÓNICA NÚMERO LA-12-M7B-012M7B997-I-82-2023, DENOMINADO “ADQUISICIÓN CONSOLIDADA DE MEDICAMENTO (CLAVE 040.000.2103.00 MORFINA) PARA LOS EJERCICIOS 2023-2024”"
},
"lifecycle": {
"section": "concluido",
"source_status": "ADJUDICADO",
"moved_at": null
},
"buyer": {
"agency": "INSTITUTO NACIONAL DE REHABILITACIÓN LUIS GUILLERMO IBARRA IBARRA",
"acronym": "INR",
"branch": "12 - SALUD",
"buying_unit": "SUBDIRECCION DE COMPRAS Y SUMINISTROS",
"requesting_unit": "unidad requiriente data",
"requesting_group": "SUBDIRECCION DE COMPRAS Y SUMINISTROS",
"entity": "INSTITUTO NACIONAL DE REHABILITACIÓN LUIS GUILLERMO IBARRA IBARRA",
"slug": "inr",
"unit_slug": "subdireccion-de-compras-y-suministros-012ndf999"
},
"classification": {
"procedure_type": "ADJUDICACIÓN DIRECTA",
"contracting_type": "ADQUISICIONES",
"publication_type": null,
"character": "INTERNACIONAL ABIERTO",
"fiscal_year": 2024,
"law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
"legal_basis_id": "22",
"exception_basis": "Art. 41 fr. I",
"internal_control_number": "CONSOLIDADO/INSABI/INRLGII/215/2023-2024 PHARMA TYCSA S.A. DE C.V.",
"supply_source_number": null
},
"schedule": {
"published_at": "2024-04-16T18:10:22.000Z",
"clarification_meeting_at": null,
"clarification_questions_deadline_at": null,
"clarification_responses_deadline_at": null,
"bid_opening_at": null,
"award_at": null,
"estimated_contract_at": "2024-01-01T06:00:00.000Z",
"site_visit_at": null,
"estimated_work_start_at": null
},
"estimated_value": {
"minimum": null,
"maximum": null,
"currency": "MXN",
"updated_at": null
},
"lots": [
{
"number": "1",
"name": "PARTIDA SOLA",
"description": "PARTIDA SOLA",
"requirement_group_id": "1",
"items": [
{
"number": "1",
"cucop_code": "25301-1519",
"specific_item_code": "25301",
"cucop_description": "040.000.2103.00 MORFINA SOLUCION INYECTABLE 10 MG 5 AMPOLLETAS",
"description": "MORFINA SOLUCIÓN INYECTABLE. CADA AMPOLLETA CONTIENE SULFATO DE MORFINA 10 MG. ENVASE CON 5 AMPOLLETAS",
"requested_quantity": "69",
"minimum_quantity": "69",
"maximum_quantity": "172",
"unit": "PIEZA",
"minimum_amount": null,
"maximum_amount": null
}
]
}
],
"awards": [
{
"id": "C-2024-00041942",
"internal_reference": "CONSOLIDADO/INSABI/INRLGII/215/2023-2024 PHARMA TYCSA S.A. DE C.V.",
"title": "CONSOLIDADO/INSABI/INRLGII/215/2023-2024 PHARMA TYCSA S.A. DE C.V.",
"status": "PUBLICADO",
"contractor": {
"name": "PHARMA TYCSA SA DE CV",
"normalized_name": "PHARMA TYCSA",
"rfc_type": null,
"slug": "pharma-tycsa"
},
"contract_period": {
"published_at": "2024-04-16T18:10:22.000Z",
"starts_at": "2024-01-01T06:00:00.000Z",
"ends_at": "2024-12-31T06:00:00.000Z"
},
"value": {
"subtotal": "218674.8",
"tax": "0",
"total": "218674.8",
"maximum_subtotal": "545102.4",
"maximum_total": "545102.4",
"currency": "MXN"
},
"open_contract_type": null,
"quantity": null,
"exercised_quantity": null,
"participants": [],
"line_items": [
{
"number": "0",
"cucop_code": "25301-1519",
"description": "MORFINA SOLUCIÓN INYECTABLE. CADA AMPOLLETA CONTIENE SULFATO DE MORFINA 10 MG. ENVASE CON 5 AMPOLLETAS",
"unit": "PIEZA",
"requested_quantity": "69",
"awarded_quantity": null,
"unit_price": "3169.2",
"subtotal": "218674.8",
"tax": null,
"other_taxes": null,
"total": "218674.8"
}
]
}
],
"documents": [
{
"id": null,
"annex_number": 1,
"document_type": null,
"description": "JUSTIFICACIÓN DE EXCEPCIÓN",
"filename": "ACTA DE FALLO I-82.pdf",
"availability": "available",
"size_bytes": "1138633",
"mime_type": "application/pdf",
"sha256": null,
"uploaded_at": "2025-12-01T11:40:02.826Z",
"updated_at": "2025-12-01T11:40:02.827Z"
},
{
"id": null,
"annex_number": 1,
"document_type": null,
"description": "ANEXO TÉCNICO",
"filename": "CONTRATO 215 PHARMA TYCSA S.A. DE C.V.docx",
"availability": "available",
"size_bytes": "122012",
"mime_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"sha256": null,
"uploaded_at": "2025-12-01T11:40:04.954Z",
"updated_at": "2025-12-01T11:40:04.955Z"
},
{
"id": null,
"annex_number": 4,
"document_type": null,
"description": "OFICIO DE ADJUDICACIÓN",
"filename": "C.A. 215 PHARMA TYCSA S.A. DE C.V..docx",
"availability": "available",
"size_bytes": "275244",
"mime_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"sha256": null,
"uploaded_at": "2025-12-01T11:40:06.608Z",
"updated_at": "2025-12-01T11:40:06.609Z"
}
],
"alternates": [],
"similar": [
{
"numero_procedimiento": "aa-12-ndf-012ndf999-i-905-2023",
"nombre_procedimiento": "CONSOLIDADO/INSABI/INRLGII/121/2023-2024 PHARMA TYCSA, S.A. DE C.V.",
"dependencia": "INR",
"siglas": "INR",
"score": 0.007128060288907889
},
{
"numero_procedimiento": "aa-12-ndf-012ndf999-n-526-2023",
"nombre_procedimiento": "610 LABORATORIOS PISA",
"dependencia": "INR",
"siglas": "INR",
"score": 0.026686131954193115
},
{
"numero_procedimiento": "aa-12-ncd-012ncd001-n-78-2024",
"nombre_procedimiento": "MORFINA SOLUCIÓN INYECTABLE",
"dependencia": "INER",
"siglas": "INER",
"score": 0.04081665983000793
},
{
"numero_procedimiento": "aa-12-ncd-012ncd001-n-124-2023",
"nombre_procedimiento": "MORFINA SOLUCION INYECTABLE",
"dependencia": "INER",
"siglas": "INER",
"score": 0.04258590682828811
},
{
"numero_procedimiento": "aa-12-nde-012nde001-i-301-2024",
"nombre_procedimiento": "MEDICAMENTO, MORFINA SOLUCIÓN INYECTABLE.",
"dependencia": "INPER",
"siglas": "INPER",
"score": 0.051682051915998395
},
{
"numero_procedimiento": "aa-12-nde-012nde001-n-189-2023",
"nombre_procedimiento": "MEDICAMENTO, MORFINA SOLUCIÓN.",
"dependencia": "INPER",
"siglas": "INPER",
"score": 0.05466479388861456
}
]
}